EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Olaparib Combined with DDR Inhibitors Effectively Prevents EMT and Affects miRNA Regulation in TP53-Mutated Epithelial Ovarian Cancer Cell Lines

Patrycja Gralewska iD, Łukasz Biegała iD, Arkadiusz Gajek iD, Izabela Szymczak-Pajor iD, Agnieszka Marczak iD, Agnieszka Śliwińska iD, Aneta Rogalska iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26020693 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Patrycja Gralewska und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biophysics, Institute of Biophysics, Faculty of Biology and Environmental Protection, University of Lodz, 141/143 Pomorska Stre…. Hauptthemen laut MEDLINE: Phthalazines, Epithelial-Mesenchymal Transition, MicroRNAs, Piperazines. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Center, National Science Centre, Poland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epithelial ovarian cancer (EOC) remains a leading cause of gynecologic cancer mortality. Despite advances in treatment, metastatic progression and resistance to standard therapies significantly worsen patient outcomes. Epithelial–mesenchymal transition (EMT) is a critical process in metastasis, enabling cancer cells to gain invasive and migratory capabilities, often driven by changing miRNA expression involved in the regulation of pathological processes like drug resistance. Targeted therapies like PARP inhibitors (PARPi) have improved outcomes, particularly in BRCA-mutated and DNA repair-deficient tumors; however, resistance and limited efficacy in advanced stages remain challenges. Recent studies highlight the potential synergy of PARPi with DNA damage response (DDR) inhibitors, such as ATR and CHK1 inhibitors, which disrupt cancer cell survival pathways under stress. This study investigated the combined effects of olaparib with ATR and CHK1 inhibitors (ATRi and CHK1i) on migration, invasion, and EMT-related protein expression and miRNA expression in ovarian cancer cell lines OV-90 and SKOV-3. The results demonstrated enhanced cytotoxicity, inhibition of migration and invasion, and modulation of miRNAs linked to metastasis. These findings suggest that combination therapies targeting DNA repair and cell cycle pathways may offer a novel, more effective approach to managing advanced EOC and reducing metastatic spread.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhthalazinesEpithelial-Mesenchymal TransitionMicroRNAsPiperazinesCarcinoma, Ovarian EpithelialOvarian NeoplasmsTumor Suppressor Protein p53Poly(ADP-ribose) Polymerase InhibitorsHumansFemaleCell Line, TumorCell MovementGene Expression Regulation, NeoplasticMutationCheckpoint Kinase 1DNA RepairDNA Damage

Stichwörter der Autor:innen

DDR inhibitorsEMTPARPimiRNAovarian cancer

Substanzen

olaparibPhthalazinesMicroRNAsPiperazinesTumor Suppressor Protein p53Poly(ADP-ribose) Polymerase InhibitorsTP53 protein, humanCheckpoint Kinase 1CHEK1 protein, human

Autor:innen und Institutionen

  • Department of Medical Biophysics, Institute of Biophysics, Faculty of Biology and Environmental Protection, University of Lodz, 141/143 Pomorska Street, 90-236 Lodz, Poland.
  • Department of Nucleic Acid Biochemistry, Medical University of Lodz, 251 Pomorska Street, 92-213 Lodz, Poland.

ORCID-Profile: Patrycja Gralewska, Łukasz Biegała, Arkadiusz Gajek, Izabela Szymczak-Pajor, Agnieszka Marczak, Agnieszka Śliwińska, Aneta Rogalska

Förderung

  • National Science Center
  • National Science Centre, Poland

Zitieren

APA

Gralewska, P., Biegała, Ł., Gajek, A., Szymczak-Pajor, I., Marczak, A., Śliwińska, A., & Rogalska, A. (2025). Olaparib Combined with DDR Inhibitors Effectively Prevents EMT and Affects miRNA Regulation in TP53-Mutated Epithelial Ovarian Cancer Cell Lines. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26020693

Vancouver

Gralewska P, Biegała Ł, Gajek A, Szymczak-Pajor I, Marczak A, Śliwińska A, et al. Olaparib Combined with DDR Inhibitors Effectively Prevents EMT and Affects miRNA Regulation in TP53-Mutated Epithelial Ovarian Cancer Cell Lines. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26020693

BibTeX
@article{Gralewska2025,
  author = {Gralewska, Patrycja and Biegała, Łukasz and Gajek, Arkadiusz and Szymczak-Pajor, Izabela and Marczak, Agnieszka and Śliwińska, Agnieszka and Rogalska, Aneta},
  title = {Olaparib Combined with DDR Inhibitors Effectively Prevents EMT and Affects miRNA Regulation in TP53-Mutated Epithelial Ovarian Cancer Cell Lines},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26020693}
}
Kostenlos starten →